NEWS ER
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
Positive
▪️Revenue increased 12% year-over-year to $14.1 million
▪️Margin improved to 50% from 38.8% in the previous year
▪️Achieved adjusted EBITDA of $2.0 million, compared to a loss of $1.7 million last year
▪️Reported net income of $1.3 million
▪️Total costs and operating expenses decreased by $2.4 million or 15.8%
▪️Cost of oncology services decreased by 8.0%
▪️Research and development expenses reduced by 47.9%
▪️General and administrative expenses decreased by 14.0%
▪️Net cash provided by operating activities was $311,000
▪️Company has no debt
▪️Revenue increased 12% year-over-year to $14.1 million
▪️Margin improved to 50% from 38.8% in the previous year
▪️Achieved adjusted EBITDA of $2.0 million, compared to a loss of $1.7 million last year
▪️Reported net income of $1.3 million
▪️Total costs and operating expenses decreased by $2.4 million or 15.8%
▪️Cost of oncology services decreased by 8.0%
▪️Research and development expenses reduced by 47.9%
▪️General and administrative expenses decreased by 14.0%
▪️Net cash provided by operating activities was $311,000
▪️Company has no debt
Negative
▪️Potential revenue and margin volatility expected in coming quarters
▪️Potential revenue and margin volatility expected in coming quarters
▪️Cash on hand decreased to $2.9 million from $3.6 million at the end of the previous quarter
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment